Gómez-Escobedo, R.; Méndez-Álvarez, D.; Vázquez, C.; Saavedra, E.; Vázquez, K.; Alcántara-Farfán, V.; Cordero-Martínez, J.; Gonzalez-Gonzalez, A.; Rivera, G.; Nogueda-Torres, B.
Molecular Docking-Based Virtual Screening of FDA-Approved Drugs Using Trypanothione Reductase Identified New Trypanocidal Agents. Molecules 2024, 29, 3796.
https://doi.org/10.3390/molecules29163796
AMA Style
Gómez-Escobedo R, Méndez-Álvarez D, Vázquez C, Saavedra E, Vázquez K, Alcántara-Farfán V, Cordero-Martínez J, Gonzalez-Gonzalez A, Rivera G, Nogueda-Torres B.
Molecular Docking-Based Virtual Screening of FDA-Approved Drugs Using Trypanothione Reductase Identified New Trypanocidal Agents. Molecules. 2024; 29(16):3796.
https://doi.org/10.3390/molecules29163796
Chicago/Turabian Style
Gómez-Escobedo, Rogelio, Domingo Méndez-Álvarez, Citlali Vázquez, Emma Saavedra, Karina Vázquez, Verónica Alcántara-Farfán, Joaquín Cordero-Martínez, Alonzo Gonzalez-Gonzalez, Gildardo Rivera, and Benjamín Nogueda-Torres.
2024. "Molecular Docking-Based Virtual Screening of FDA-Approved Drugs Using Trypanothione Reductase Identified New Trypanocidal Agents" Molecules 29, no. 16: 3796.
https://doi.org/10.3390/molecules29163796
APA Style
Gómez-Escobedo, R., Méndez-Álvarez, D., Vázquez, C., Saavedra, E., Vázquez, K., Alcántara-Farfán, V., Cordero-Martínez, J., Gonzalez-Gonzalez, A., Rivera, G., & Nogueda-Torres, B.
(2024). Molecular Docking-Based Virtual Screening of FDA-Approved Drugs Using Trypanothione Reductase Identified New Trypanocidal Agents. Molecules, 29(16), 3796.
https://doi.org/10.3390/molecules29163796